JSE gains on Covid-19 vaccine optimism
US officials have said that vaccination could be rolled out by mid-December
24 November 2020 - 11:13Lindiwe TsoboThe JSE was firmer on Tuesday, with global peers mixed as investors pinned hopes for economic revival on Covid-19 vaccines.The vaccine developed by AstraZeneca and Oxford University is the third major trial to report success after US-based Moderna and Pfizer with Germany's BioNTech, sending pandemic-weary investors to take on risk in hopes of a swift economic recovery...
BPremiumThis article is reserved for our subscribers.A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.Read more: Business Day »
Why the optimism? Is massive death and population reduction such a boon for investors?